Teva’s ‘skinny label’ generic didn’t cause infringement of GSK’s patent, judge finds

  1. Teva’s ‘skinny label’ generic didn’t cause infringement of GSK’s patent, judge finds  BioPharma Dive

  2. Teva won’t owe $235M penalty in Coreg ‘carve-out’ fight with GlaxoSmithKline  FiercePharma

    3. Full coverage